File: /home/govancoz/mail/.spam/new/1705793892.M139737P1162753.zacp120.ve.host,S=9177,W=9341
Return-Path: <rge001@barwaqtloan.com>
Delivered-To: govancoz+spam@zacp120.ve.host
Received: from zacp120.ve.host
by zacp120.ve.host with LMTP
id +eRNB2RZrGUBvhEAvcbEzQ
(envelope-from <rge001@barwaqtloan.com>)
for <govancoz+spam@zacp120.ve.host>; Sun, 21 Jan 2024 01:38:12 +0200
Return-path: <rge001@barwaqtloan.com>
Envelope-to: mike@govan.co.za
Delivery-date: Sun, 21 Jan 2024 01:38:12 +0200
Received: from [118.194.251.200] (port=56282 helo=mail.barwaqtloan.com)
by zacp120.ve.host with esmtps (TLS1.3) tls TLS_AES_256_GCM_SHA384
(Exim 4.96.2)
(envelope-from <rge001@barwaqtloan.com>)
id 1rRKul-004sG4-0V
for mike@govan.co.za;
Sun, 21 Jan 2024 01:38:12 +0200
Received: from localhost (localhost [127.0.0.1])
by mail.barwaqtloan.com (Postfix) with ESMTP id BEA6398A304;
Sat, 20 Jan 2024 22:33:34 +0700 (+07)
Received: from mail.barwaqtloan.com ([127.0.0.1])
by localhost (mail.barwaqtloan.com [127.0.0.1]) (amavisd-new, port 10032)
with ESMTP id am_Q96wfjxGE; Sat, 20 Jan 2024 22:33:34 +0700 (+07)
Received: from localhost (localhost [127.0.0.1])
by mail.barwaqtloan.com (Postfix) with ESMTP id 0CF66989A16;
Sat, 20 Jan 2024 22:33:25 +0700 (+07)
DKIM-Filter: OpenDKIM Filter v2.10.3 mail.barwaqtloan.com 0CF66989A16
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=barwaqtloan.com;
s=7B404F96-7D41-11EE-B202-29BD998C31F1; t=1705764805;
bh=Ue/bKamQCT7GUry02n96s7UVo/7YG5TdcqFxJCdPAUY=;
h=MIME-Version:To:From:Date:Message-Id;
b=CblXl4BE6Bt65cZ0oFI71v3u9dI5GzNQ9CaVV/UYeoCETfOTzeRbsoHqpfMcAqNXY
ZwuILwI3GtehG7kYiXi/N4Svqq7YGHcvW0QHMnNdfyW964a7ZV3PIJD3I7qX+q29OG
QMCgSX0H/cZSEvWfThNqklYQU6EUQGYrxAnpbeAJDCKyeGA+DfQB2BxZZpJdPMDHZn
DeMZ9xf4kCwFm6En0MOYpK0drQhtnLqK03Y/zA3mwTXd3Hqzya3PkSR5+8Jwsb7t+6
HAI3RvCTrHc8u/hJXHgfjdTxzY7umv9kD7pQp2NEnHzzBDexcvJ85kwRStyZ4LUTUS
7FtiXhdgz2+Ug==
X-Virus-Scanned: amavisd-new at mail.barwaqtloan.com
Received: from mail.barwaqtloan.com ([127.0.0.1])
by localhost (mail.barwaqtloan.com [127.0.0.1]) (amavisd-new, port 10026)
with ESMTP id Nx8CZkvlEKpN; Sat, 20 Jan 2024 22:33:24 +0700 (+07)
Received: from SRV-AWSWEB.ec2.internal (ec2-3-211-154-106.compute-1.amazonaws.com [3.211.154.106])
by mail.barwaqtloan.com (Postfix) with ESMTPSA id 02B878B3E7D;
Sat, 20 Jan 2024 22:33:07 +0700 (+07)
Content-Type: multipart/alternative; boundary="===============1740428233=="
MIME-Version: 1.0
To: Recipients <rge001@barwaqtloan.com>
From: "Dr. Yasunobu Otsuga" <rge001@barwaqtloan.com>
Date: Sat, 20 Jan 2024 12:30:36 -0300
Reply-To: dr.yasunobu1@gmail.com
Message-Id: <20240120153308.02B878B3E7D@mail.barwaqtloan.com>
X-Spam-Status: Yes, score=13.2
X-Spam-Score: 132
X-Spam-Bar: +++++++++++++
X-Spam-Report: Spam detection software, running on the system "zacp120.ve.host",
has identified this incoming email as possible spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Hello Daito Pharma Co., Ltd. is a Japan-based manufacturing
pharmaceutical company engaged in the pharmaceutical ingredients and formulation
business . Are you interested in working with us to be our [...]
Content analysis details: (13.2 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was
blocked. See
http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
for more information.
[URIs: barwaqtloan.com]
0.2 FREEMAIL_REPLYTO_END_DIGIT Reply-To freemail username ends in
digit
[dr.yasunobu1[at]gmail.com]
0.0 T_SPF_PERMERROR SPF: test of record failed (permerror)
0.5 SUBJ_ALL_CAPS Subject is all capitals
0.0 HTML_MESSAGE BODY: HTML included in message
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
3.6 RCVD_IN_PBL RBL: Received via a relay in Spamhaus PBL
[118.194.251.200 listed in zen.spamhaus.org]
2.0 PYZOR_CHECK Listed in Pyzor
(https://pyzor.readthedocs.io/en/latest/)
1.3 RCVD_IN_VALIDITY_RPBL RBL: Relay in Validity RPBL,
https://senderscore.org/blocklistlookup/
[118.194.251.200 listed in bl.score.senderscore.com]
0.0 KAM_DMARC_STATUS Test Rule for DKIM or SPF Failure with Strict
Alignment
-0.0 T_SCC_BODY_TEXT_LINE No description available.
2.0 RDNS_NONE Delivered to internal network by a host with no rDNS
0.1 DKIM_INVALID DKIM or DK signature exists, but is not valid
0.9 FSL_BULK_SIG Bulk signature with no Unsubscribe
2.5 FREEMAIL_FORGED_REPLYTO Freemail in Reply-To, but not From
X-Spam-Flag: YES
Subject: ***SPAM*** WE INTEND TO PARTNER WITH YOU.
You will not see this in a MIME-aware mail reader.
--===============1740428233==
Content-Type: text/plain; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
Hello
Daito Pharma Co., Ltd. is a Japan-based manufacturing pharmaceutical comp=
any engaged in the pharmaceutical ingredients and formulation business . Ar=
e you interested in working with us to be our company representative in you=
r country, The Republic of South Africa, for a period of five years contrac=
t? Please Kindly let us know if you are interested while I direct you to m=
y working company email address
Apologies for using my personal email address for these proposals. However=
, The reason was to get an immediate notification from you once you respond=
ed.
Best regards,
Dr. Yasunobu Otsuga
President & CEO
Daito Pharmaceutical Co., Ltd.
326 Yokamachi, Toyama City, Toyama Prefecture 939-8567
--===============1740428233==
Content-Type: text/html; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body
<HTML><head><meta http-equiv=3D"Content-Type" content=3D"text/html; charset=
=3Diso-8859-1"/></head><BODY><P style=3D"FONT-SIZE: small; FONT-FAMILY: Ari=
al, Helvetica, sans-serif; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRA=
NSFORM: none; FONT-WEIGHT: 400; COLOR: rgb(34,34,34); FONT-STYLE: normal; O=
RPHANS: 2; WIDOWS: 2; LETTER-SPACING: normal; BACKGROUND-COLOR: rgb(255,255=
,255); TEXT-INDENT: 0px; font-variant-ligatures: normal; font-variant-caps:=
normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial=
; text-decoration-style: initial; text-decoration-color: initial">Hello</P>
<P style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; WH=
ITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 40=
0; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-=
SPACING: normal; BACKGROUND-COLOR: rgb(255,255,255); TEXT-INDENT: 0px; font=
-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-=
width: 0px; text-decoration-thickness: initial; text-decoration-style: init=
ial; text-decoration-color: initial">Daito Pharma Co., Ltd. is a Japan-base=
d manufacturing pharmaceutical company engaged in the pharmaceutical =
ingredients and formulation business . Are you interested in working with u=
s to be our company representative in your country, The Republic of South A=
frica, for a period of five years contract? Please Kindly let us know=
if you are interested while I direct you to my working company email addre=
ss</P>
<P style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; WH=
ITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 40=
0; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-=
SPACING: normal; BACKGROUND-COLOR: rgb(255,255,255); TEXT-INDENT: 0px; font=
-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-=
width: 0px; text-decoration-thickness: initial; text-decoration-style: init=
ial; text-decoration-color: initial">Apologies for using my personal email =
address for these proposals. However, The reason was to get an immediate no=
tification from you once you responded.</P>
<P style=3D"FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif; WH=
ITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; FONT-WEIGHT: 40=
0; COLOR: rgb(34,34,34); FONT-STYLE: normal; ORPHANS: 2; WIDOWS: 2; LETTER-=
SPACING: normal; BACKGROUND-COLOR: rgb(255,255,255); TEXT-INDENT: 0px; font=
-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-=
width: 0px; text-decoration-thickness: initial; text-decoration-style: init=
ial; text-decoration-color: initial">Best regards,<BR>Dr. Yasunobu Ot=
suga<BR>President & CEO<BR>Daito Pharmaceutical Co., Ltd.<BR>326 Yokama=
chi, Toyama City, Toyama Prefecture 939-8567</P></BODY></HTML>
--===============1740428233==--